Is a
Product attributes
Industry
Product Parent Company
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with both empagliflozin and linagliptin is appropriate.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.